
In the News
Cebix is proud to announce our new Clinical Trial Manager, Mark Daniels.
Mark Daniels has more than 13 years of pharmaceutical industry experience. Prior to joining Cebix, Mark has managed all phases of global clinical development studies with a strong emphasis on neurological diseases such as Alzheimer’s Disease at Elan Pharmaceuticals and Multiple Sclerosis and Oncology at Biogen Idec. He obtained his Bachelor’s of Sciences degree in Psychobiology from the University of California, at Los Angeles.
